BioXcel Therapeutics, Inc. Supply Commitment, Remaining Minimum Amount Committed
BioXcel Therapeutics, Inc. (BTAI) had Supply Commitment, Remaining Minimum Amount Committed of $10.00 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Commitment and Contingencies
us-gaap:SignificantSupplyCommitmentRemainingMinimumAmountCommitted · last filed 2024-03-22
- 2022-09-30: Supply Commitment, Remaining Minimum Amount Committed $10.00M.
- 2022-04-30: Supply Commitment, Remaining Minimum Amount Committed $10.00M.
| Period end | Supply Commitment, Remaining Minimum Amount Committed |
|---|---|
| 2022-09-30 | $10.00M 10-Q · filed 2022-11-14 |
| 2022-04-30 | $10.00M 10-K · filed 2024-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |